DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rituxan (Rituximab) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (193)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 193   Next >>

Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-22

Patient: female

Reactions: Progressive Multifocal Leukoencephalopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan
    Dosage: 375/m2, unk
    Indication: Idiopathic Thrombocytopenic Purpura

Rituxan
    Indication: Lupus-Like Syndrome

Rituxan

Other drugs received by patient: Prednisone TAB; Prednisone TAB; Panglobulin; Calcium Carbonate; Ergocalciferol; Zoledronic Acid; Iron Polysaccharide; Conjugated Estrogens; Imuran; Omeprazole; Sumatriptan; Mirtazapine; Ascorbic Acid; Sulfamethoxazole; Prednisone TAB; Romiplostim; Atenolol; Prednisone TAB; Danazol; Acetaminophen; Alprazolam



Possible Rituxan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: male

Reactions: Lymphoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 68 year old male

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-17

Patient: 68 year old male

Reactions: Hepatitis B

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Splenic Marginal Zone Lymphoma

Doxorubicin Hydrochloride
    Indication: Splenic Marginal Zone Lymphoma

Prednisone TAB
    Indication: Immunosuppression

Rituxan
    Indication: Splenic Marginal Zone Lymphoma

Vincristine
    Indication: Splenic Marginal Zone Lymphoma



Possible Rituxan side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: male, weighing 91.7 kg (201.7 pounds)

Reactions: Pneumonia, Anaemia, Pancytopenia, Febrile Neutropenia, Respiratory Failure, Muscle Abscess, Thrombocytopenia, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Rituxan
    Dosage: 150 milligram
    Start date: 2012-05-14

Rituxan
    Start date: 2012-06-22

Rituxan
    Start date: 2012-07-19
    End date: 2012-07-20

Rituxan
    Dosage: 17.8571 milligram
    Start date: 2012-08-04

Vidaza
    Dosage: 150 milligram
    Start date: 2012-05-14

Vidaza
    Dosage: 150 milligram
    Start date: 2012-07-19
    End date: 2012-07-20

Other drugs received by patient: Procrit; Fluticasone Propionate; Folic Acid; Hydrocortisone-Pramoxine; Metoprolol Tartrate; Rosuvastatin; Meropenem; Vancomycin; Dextrose; Acetaminophen; Calcium + Vitamin D; Ciprofloxacin-Dexamethasone Otic; Diphenhydramine Hydrochloride; Filgrastim; Multi-Vitamins; Phenylephrine Hydrochloride; Acetaminophen; Naproxen; Whole Blood; Prednisone TAB; Vitamin B-12; Acetaminophen; Benazepril Hydrochloride; Augmentin '500'; Amlodipine; Omeprazole; Sodium Chloride



Possible Rituxan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-15

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 70 year old

Reported by a pharmacist from United States on 2012-08-09

Patient: 70 year old

Reactions: Death, Histiocytosis Haematophagic, Chills

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Indication: Lymphoma
    Start date: 2012-05-14

Bendamustine Hydrochloride
    Start date: 2012-05-15

Rituxan
    Dosage: splitted dose.
    Start date: 2012-05-15

Rituxan
    Indication: Lymphoma
    Start date: 2012-05-14



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-09

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Activase
    Indication: Cerebral Artery Occlusion

Rituxan
    Indication: Anaemia Haemolytic Autoimmune



Possible Rituxan side effects in female

Reported by a physician from United States on 2012-08-08

Patient: female

Reactions: Myocardial Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Actemra
    Indication: Rheumatoid Arthritis

Rituxan
    Indication: Rheumatoid Arthritis



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-03

Patient: male, weighing 94.0 kg (206.8 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Coumadin



Possible Rituxan side effects in female

Reported by a physician from United States on 2012-08-02

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 85 year old

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: 85 year old

Reactions: Cardiomyopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide

Cyclophosphamide
    Dosage: reduced dose
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: reduced dose
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride

Prednisone
    Dosage: reduced dose
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: daily for 5 days

Radiotherapy
    Indication: Diffuse Large B-Cell Lymphoma

Rituxan
    Indication: Diffuse Large B-Cell Lymphoma

Rituxan
    Dosage: reduced dose

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: reduced dose

Other drugs received by patient: Neupogen



Possible Rituxan side effects in female

Reported by a physician from United States on 2012-07-31

Patient: female

Reactions: B-Cell Lymphoma Refractory

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 56 year old female

Reported by a consumer/non-health professional from China on 2012-07-31

Patient: 56 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in

Reported by a physician from United States on 2012-07-27

Patient:

Reactions: Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-26

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-07-26

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-23

Patient: female

Reactions: Pulmonary Hypertension, Lung Consolidation, Regurgitation, Pneumonia, Dyspnoea Exertional, Oxygen Consumption Increased, Cough

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Digoxin; Lasix; Methotrexate; Prednisone; Telmisartan



Possible Rituxan side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: male, weighing 86.2 kg (189.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17

Patient: male

Reactions: Fungal Infection, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 2

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 3

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 4

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 3

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 2

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 4

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 2

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 3

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 2

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 3
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 1



Possible Rituxan side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17

Patient:

Reactions: Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Prednisone
    Indication: B-Cell Lymphoma

Rituxan
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Rituxan side effects in

Reported by a physician from United States on 2012-07-17

Patient:

Reactions: Thrombosis, Gastrointestinal Perforation, Left Ventricular Dysfunction, Sudden Death, Blood Disorder, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Bevacizumab
    Dosage: on day 1, every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Rituxan
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: male

Reactions: Pneumonia, Lung Infiltration, Respiratory Distress, Cough

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 69 year old female

Reported by a individual with unspecified qualification from Japan on 2012-07-12

Patient: 69 year old female

Reactions: Hepatic Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Prednisolone; Doxorubicin Hydrochloride; Cyclophosphamide; Vincristine Sulfate



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-12

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Actemra
    Indication: Product Used FOR Unknown Indication

Rituxan
    Indication: Rheumatoid Arthritis



Possible Rituxan side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female

Reactions: Myocardial Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Actemra
    Indication: Rheumatoid Arthritis

Rituxan
    Indication: Rheumatoid Arthritis



Possible Rituxan side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Actemra
    Indication: Rheumatoid Arthritis

Rituxan
    Indication: Product Used FOR Unknown Indication



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014